Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10349)
All Articles published online
|
Publishing Process of This Article
|
Jan 14, 2016 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Peng JF, Zhuang YY, Huang FT, Zhang SN. Noncoding RNAs and pancreatic cancer. World J Gastroenterol 2016; 22(2): 801-814 [PMID: 26811626 DOI: 10.3748/wjg.v22.i2.801] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i2/801.htm |
| Number | Citing Articles |
| 1 |
Zhangang Xiao, Jing Shen, Lin Zhang, Mingxing Li, Wei Hu, Chihin Cho. Therapeutic targeting of noncoding RNAs in hepatocellular carcinoma: Recent progress and future prospects (Review). Oncology Letters 2018; doi: 10.3892/ol.2018.7758
|
| 2 |
D. Moschovis, E. Vasilaki, M. Tzouvala, G. Karamanolis, H. Katifelis, E. Legaki, A. Vezakis, G. Aravantinos, M. Gazouli. Association between genetic polymorphisms in long non-coding RNAs and pancreatic cancer risk. Cancer Biomarkers 2019; 24(1): 117 doi: 10.3233/CBM-181959
|
| 3 |
Meng Zhang, Xiang Du. Noncoding RNAs in gastric cancer: Research progress and prospects. World Journal of Gastroenterology 2016; 22(29): 6610-6618 doi: 10.3748/wjg.v22.i29.6610
|
| 4 |
Panagiotis G. Adamopoulos, Georgios D. Raptis, Christos K. Kontos, Andreas Scorilas. Discovery and expression analysis of novel transcripts of the human SR-related CTD-associated factor 1 (SCAF1) gene in human cancer cells using Next-Generation Sequencing. Gene 2018; 670: 155 doi: 10.1016/j.gene.2018.05.044
|
| 5 |
Amy Makler, Ramaswamy Narayanan, Waseem Asghar. An Exosomal miRNA Biomarker for the Detection of Pancreatic Ductal Adenocarcinoma. Biosensors 2022; 12(10): 831 doi: 10.3390/bios12100831
|
| 6 |
Shaoqiang Liang, Ning Zhang, Yanming Deng, Lusi Chen, Yang Zhang, Zhenhe Zheng, Weijun Luo, Zhiqian Lv, Shaoen Li, Tao Xun. Increased Serum Level of MicroRNA-663 Is Correlated with Poor Prognosis of Patients with Nasopharyngeal Carcinoma. Disease Markers 2016; 2016: 1 doi: 10.1155/2016/7648215
|
| 7 |
Manika Jha, Richa Gupta, Rajiv Saxena. Fast and precise prediction of non-coding RNAs (ncRNAs) using sequence alignment and k-mer counting. International Journal of Information Technology 2023; 15(2): 577 doi: 10.1007/s41870-022-01064-y
|
| 8 |
Fengting Huang, Wenying Chen, Juanfei Peng, Yuanhua Li, Yanyan Zhuang, Zhe Zhu, Chunkui Shao, Wanling Yang, Herui Yao, Shineng Zhang. RETRACTED ARTICLE: LncRNA PVT1 triggers Cyto-protective autophagy and promotes pancreatic ductal adenocarcinoma development via the miR-20a-5p/ULK1 Axis. Molecular Cancer 2018; 17(1) doi: 10.1186/s12943-018-0845-6
|
| 9 |
Salman Guraya. Prognostic significance of circulating microRNA-21 expression in esophageal, pancreatic and colorectal cancers; a systematic review and meta-analysis. International Journal of Surgery 2018; 60: 41 doi: 10.1016/j.ijsu.2018.10.030
|
| 10 |
Bin Zhou, Weidong Guo, Chuandong Sun, Bingyuan Zhang, Fang Zheng. Linc00462 promotes pancreatic cancer invasiveness through the miR-665/TGFBR1-TGFBR2/SMAD2/3 pathway. Cell Death & Disease 2018; 9(6) doi: 10.1038/s41419-018-0724-5
|
| 11 |
Ingrid Garajová, Rita Balsano, Chiara Tommasi, Elisa Giovannetti. Noncoding Rnas Emerging as Novel Biomarkers in Pancreatic Cancer. Current Pharmaceutical Design 2019; 24(39): 4601 doi: 10.2174/1381612825666190119125804
|
| 12 |
Baoming Yang, Zhikai Jiao, Ningning Feng, Yueshan Zhang, Shunxiang Wang. Long non-coding RNA MIR600HG as a ceRNA inhibits the pancreatic cancer progression through regulating the miR-1197/PITPNM3 axis. Heliyon 2024; 10(2): e24546 doi: 10.1016/j.heliyon.2024.e24546
|
| 13 |
Nilabja Sikdar, Akash Bararia, Ashmita Dutta, Sudeep Banerjee. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. 2022; : 1 doi: 10.1007/978-981-16-1247-3_77-1
|
| 14 |
Lumir Kunovsky, Pavla Tesarikova, Zdenek Kala, Radek Kroupa, Petr Kysela, Jiri Dolina, Jan Trna. The Use of Biomarkers in Early Diagnostics of Pancreatic Cancer. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/5389820
|
| 15 |
Carlo Fabbri, Giulia Gibiino, Adele Fornelli, Vincenzo Cennamo, Daniela Grifoni, Michela Visani, Giorgia Acquaviva, Matteo Fassan, Sirio Fiorino, Silvia Giovanelli, Marco Bassi, Stefania Ghersi, Giovanni Tallini, Elio Jovine, Antonio Gasbarrini, Dario de Biase. Team work and cytopathology molecular diagnosis of solid pancreatic lesions. Digestive Endoscopy 2017; 29(6): 657 doi: 10.1111/den.12845
|
| 16 |
Tushar Singh Barwal, Uttam Sharma, Manjit Kaur Rana, Sonali Bazala, Ipsa Singh, Masang Murmu, Harmanpreet Singh Kapoor, Smriti Thakur, Manju Jain, Aklank Jain. A diagnostic and prognostic value of blood-based circulating long non-coding RNAs in thyroid, pancreatic and ovarian cancer. Critical Reviews in Oncology/Hematology 2022; 171: 103598 doi: 10.1016/j.critrevonc.2022.103598
|
| 17 |
Xiaole Zhu, Rong Yu, Yunpeng Peng, Yi Miao, Kuirong Jiang, Qiang Li. Identification of genomic instability related lncRNA signature with prognostic value and its role in cancer immunotherapy in pancreatic cancer. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.990661
|
| 18 |
|
| 19 |
Sathish Kumar Mungamuri. Theranostic Approach for Pancreatic Cancer. 2019; : 211 doi: 10.1016/B978-0-12-819457-7.00011-6
|
| 20 |
Sepideh Mirzaei, Mohammad Hossein Gholami, Mahmood Khaksary Mahabady, Noushin Nabavi, Amirhossein Zabolian, Seyed Mohammad Banihashemi, Amirabbas Haddadi, Maliheh Entezari, Kiavash Hushmandi, Pooyan Makvandi, Saeed Samarghandian, Ali Zarrabi, Milad Ashrafizadeh, Haroon Khan. Pre-clinical investigation of STAT3 pathway in bladder cancer: Paving the way for clinical translation. Biomedicine & Pharmacotherapy 2021; 133: 111077 doi: 10.1016/j.biopha.2020.111077
|
| 21 |
Chenhao Zhou, Shun Wang, Qiang Zhou, Jin Zhao, Xianghou Xia, Wanyong Chen, Yan Zheng, Min Xue, Feng Yang, Deliang Fu, Yirui Yin, Manar Atyah, Lunxiu Qin, Yue Zhao, Christiane Bruns, Huliang Jia, Ning Ren, Qiongzhu Dong. A Long Non-coding RNA Signature to Improve Prognostic Prediction of Pancreatic Ductal Adenocarcinoma. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01160
|
| 22 |
Maria Mortoglou, Zoey Kathleen Tabin, E. Damla Arisan, Hemant M Kocher, Pinar Uysal-Onganer. Non-coding RNAs in pancreatic ductal adenocarcinoma: New approaches for better diagnosis and therapy. Translational Oncology 2021; 14(7): 101090 doi: 10.1016/j.tranon.2021.101090
|
| 23 |
Zahra Sadat Razavi, Kasra Asgarpour, Maryam Mahjoubin-Tehran, Susan Rasouli, Haroon Khan, Mohammad Karim Shahrzad, Michael R. Hamblin, Hamed Mirzaei. Angiogenesis-related non-coding RNAs and gastrointestinal cancer. Molecular Therapy - Oncolytics 2021; 21: 220 doi: 10.1016/j.omto.2021.04.002
|
| 24 |
Nilabja Sikdar, Akash Bararia, Ashmita Dutta, Sudeep Banerjee. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. 2022; : 1525 doi: 10.1007/978-981-16-5422-0_77
|
| 25 |
Dongshen Ma, Shanshan Tang, Jing Song, Qiong Wu, Fangfang Zhang, Yun Xing, Yi Pan, Yanfeng Zhang, Jingwei Jiang, Yubin Zhang, Liang Jin. Culturing and transcriptome profiling of progenitor-like colonies derived from adult mouse pancreas. Stem Cell Research & Therapy 2017; 8(1) doi: 10.1186/s13287-017-0626-y
|
| 26 |
Arunoday Bhan, Milad Soleimani, Subhrangsu S. Mandal. Long Noncoding RNA and Cancer: A New Paradigm. Cancer Research 2017; 77(15): 3965 doi: 10.1158/0008-5472.CAN-16-2634
|
| 27 |
Feng-Ting Huang, Juan-Fei Peng, Wen-Jie Cheng, Yan-Yan Zhuang, Ling-Yun Wang, Chu-Qiang Li, Jian Tang, Wen-Ying Chen, Yuan-Hua Li, Shi-Neng Zhang. MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro. Digestive Diseases and Sciences 2017; 62(4): 944 doi: 10.1007/s10620-017-4472-7
|
| 28 |
Cristiane Raquel Dias Francischini, Carolina Rodrigues Mendonça, Kênia Alves Barcelos, Marco Augusto Machado Silva, Ana Flávia Machado Botelho. Antitumor effects of oleandrin in different types of cancers: Systematic review. Toxicon 2022; 216: 15 doi: 10.1016/j.toxicon.2022.06.010
|
| 29 |
|
| 30 |
Yutong Zhao, Cheng Qin, Bangbo Zhao, Yuanyang Wang, Zeru Li, Tianyu Li, Xiaoying Yang, Weibin Wang. Pancreatic cancer stemness: dynamic status in malignant progression. Journal of Experimental & Clinical Cancer Research 2023; 42(1) doi: 10.1186/s13046-023-02693-2
|
| 31 |
Yinghao Lv, Shuai Huang. Role of non‑coding RNA in pancreatic cancer (Review). Oncology Letters 2019; doi: 10.3892/ol.2019.10758
|
| 32 |
Peeter Karihtala, Katja Porvari, Ylermi Soini, Matti Eskelinen, Petri Juvonen, Kirsi-Maria Haapasaari. Expression Levels of microRNAs miR-93 and miR-200a in Pancreatic Adenocarcinoma with Special Reference to Differentiation and Relapse-Free Survival. Oncology 2019; 96(3): 164 doi: 10.1159/000494274
|
| 33 |
Patrick Wald, X. Shawn Liu, Cory Pettit, Mary Dillhoff, Andrei Manilchuk, Carl Schmidt, Evan Wuthrick, Wei Chen, Terence M. Williams. Prognostic value of microRNA expression levels in pancreatic adenocarcinoma: a review of the literature. Oncotarget 2017; 8(42): 73345 doi: 10.18632/oncotarget.20277
|
| 34 |
Zheng-Lin Ou, Zhen Luo, Ye-Bin Lu. Long non-coding RNA HULC as a diagnostic and prognostic marker of pancreatic cancer. World Journal of Gastroenterology 2019; 25(46): 6728-6742 doi: 10.3748/wjg.v25.i46.6728
|
| 35 |
Francine B. de Abreu, Xiaoying Liu, Gregory J. Tsongalis. miRNA analysis in pancreatic cancer: the Dartmouth experience. Clinical Chemistry and Laboratory Medicine (CCLM) 2017; 55(5) doi: 10.1515/cclm-2017-0046
|
| 36 |
Mohammad Khan, Shafquat Azim, Haseeb Zubair, Arun Bhardwaj, Girijesh Patel, Moh’d Khushman, Seema Singh, Ajay Singh. Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward. International Journal of Molecular Sciences 2017; 18(4): 779 doi: 10.3390/ijms18040779
|
| 37 |
Sen Yang, Yan Wang, Shuangquan Zhang, Xuemei Hu, Qin Ma, Yuan Tian. NCResNet: Noncoding Ribonucleic Acid Prediction Based on a Deep Resident Network of Ribonucleic Acid Sequences. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00090
|
| 38 |
Silvia Ottaviani, Justin Stebbing, Adam E. Frampton, Sladjana Zagorac, Jonathan Krell, Alexander de Giorgio, Sara M. Trabulo, Van T. M. Nguyen, Luca Magnani, Hugang Feng, Elisa Giovannetti, Niccola Funel, Thomas M. Gress, Long R. Jiao, Ylenia Lombardo, Nicholas R. Lemoine, Christopher Heeschen, Leandro Castellano. TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression. Nature Communications 2018; 9(1) doi: 10.1038/s41467-018-03962-x
|
| 39 |
Yiping Zhu, Fang Wu, Weiwei Gui, Nan Zhang, Erik Matro, Linghua Zhu, Daniel Turunen Eserberg, Xihua Lin, Hua Lu. A positive feedback regulatory loop involving the lncRNA PVT1 and HIF-1α in pancreatic cancer. Journal of Molecular Cell Biology 2021; 13(9): 676 doi: 10.1093/jmcb/mjab042
|
| 40 |
Qing Han, Junhe Li, Jianping Xiong, Zhiwang Song. Long noncoding RNA LINC00514 accelerates pancreatic cancer progression by acting as a ceRNA of miR-28-5p to upregulate Rap1b expression. Journal of Experimental & Clinical Cancer Research 2020; 39(1) doi: 10.1186/s13046-020-01660-5
|
| 41 |
Jérôme Raffenne, Jérôme Cros. La caractérisation moléculaire définit plusieurs sous-types d’adénocarcinome canalaire du pancréas. Bulletin du Cancer 2018; 105(1): 55 doi: 10.1016/j.bulcan.2017.11.010
|
| 42 |
Shan Zhang, Weiwei Shi, Wei Hu, Ding Ma, Dongliang Yan, Kuanyong Yu, Guang Zhang, Yin Cao, Junhua Wu, Chunping Jiang, Zhongxia Wang. <p>DEP Domain-Containing Protein 1B (DEPDC1B) Promotes Migration and Invasion in Pancreatic Cancer Through the Rac1/PAK1-LIMK1-Cofilin1 Signaling Pathway</p>. OncoTargets and Therapy 2020; : 1481 doi: 10.2147/OTT.S229055
|
| 43 |
Gwen Lomberk, Nelson Dusetti, Juan Iovanna, Raul Urrutia. Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicine. Nature Communications 2019; 10(1) doi: 10.1038/s41467-019-11812-7
|
| 44 |
Ziyu Liang, Shaomei Tang, Rongquan He, Wei Luo, Shanyu Qin, Haixing Jiang. The effect and mechanism of miR-30e-5p targeting SNAI1 to regulate epithelial-mesenchymal transition on pancreatic cancer. Bioengineered 2022; 13(4): 8013 doi: 10.1080/21655979.2022.2050880
|
| 45 |
Bingqing Hui, Hao Ji, Yetao Xu, Juan Wang, Zhonghua Ma, Chongguo Zhang, Keming Wang, Yan Zhou. RREB1-induced upregulation of the lncRNA AGAP2-AS1 regulates the proliferation and migration of pancreatic cancer partly through suppressing ANKRD1 and ANGPTL4. Cell Death & Disease 2019; 10(3) doi: 10.1038/s41419-019-1384-9
|
| 46 |
Marine Lambert, Abderrahim Benmoussa, Idrissa Diallo, Katheryn Ouellet-Boutin, Véronique Dorval, Nathalie Majeau, Charles Joly-Beauparlant, Arnaud Droit, Alain Bergeron, Bernard Têtu, Yves Fradet, Frédéric Pouliot, Patrick Provost. Identification of Abundant and Functional dodecaRNAs (doRNAs) Derived from Ribosomal RNA. International Journal of Molecular Sciences 2021; 22(18): 9757 doi: 10.3390/ijms22189757
|
| 47 |
Xu Lu, Yu Zhang, Guangfei Xie, Ye Ding, Hui Cong, Shihai Xuan. Exosomal non‑coding RNAs: Novel biomarkers with emerging clinical applications in gastric cancer (Review). Molecular Medicine Reports 2020; doi: 10.3892/mmr.2020.11519
|
| 48 |
Zhaoyun Liu, Mei Han, Nanhao Meng, Jingyi Luo, Rong Fu, Jayeeta Ghose. lncRNA MSTRG.29039.1 Promotes Proliferation by Sponging hsa-miR-12119 via JAK2/STAT3 Pathway in Multiple Myeloma. Oxidative Medicine and Cellular Longevity 2021; 2021: 1 doi: 10.1155/2021/9969449
|
| 49 |
Kan‐Fei Gao, Yu‐Fang Zhao, Wu‐Jun Liao, Guo‐Li Xu, Jian‐Dong Zhang. CERS6‐AS1 promotes cell proliferation and represses cell apoptosis in pancreatic cancer via miR‐195‐5p/WIPI2 axis. The Kaohsiung Journal of Medical Sciences 2022; 38(6): 542 doi: 10.1002/kjm2.12522
|